Daewoong Pharmaceutical
CEP Certificates (EDQM COS List)

Daewoong Pharmaceutical

CEP Database

Certificates of Suitability to the European Pharmacopoeia (CEP), issued by the EDQM.

ChemicalChemical and TSE South Korea
  • Total Records 6
  • Latest End Date 2025-11-03
  • Data Source EDQM
  • Last Updated 2024-12-17
All
6
View
Chemical
5
View
Chemical and TSE
1
View
Valid
4
View
Withdrawn
2
View
Company Overview

Company

Daewoong Pharmaceutical

Country

South Korea

Website

Visit Website

Email

urahwan@daewoong.co.kr

Social Profiles

LinkedIn
Company Snapshot

Daewoong Pharmaceutical

Bongeunsa-ro114-gil 12, Gangnam-gu, Seoul, Korea

South Korea

www.daewoong.com/en/main/index urahwan@daewoong.co.kr View on Map
CEP Records Timeline (6 records)
2024
17 Dec
Chemical Valid

Product

Ursodeoxycholic acid, Process IV

Substance

DAEWOONG BIO INC. Hwaseong-Si KR

Certificate No.

CEP 2022-479 - Rev 01

Substance No.

1275

Issue Date

2024-12-17

End Date

-

South Korea

Country

South Korea

Identifiers

Certificate No.: CEP 2022-479 - Rev 01
Substance No.: 1275

2024
26 Jun
Chemical Valid

Product

Ursodeoxycholic acid, Process III

Substance

DAEWOONG BIO INC. Hwaseong-Si KR

Certificate No.

CEP 2020-134 - Rev 01

Substance No.

1275

Issue Date

2024-06-26

End Date

-

South Korea

Country

South Korea

Identifiers

Certificate No.: CEP 2020-134 - Rev 01
Substance No.: 1275

2018
30 Jul
Chemical and TSE Withdrawn by Holder

Product

Ursodeoxycholic acid

Substance

DAEWOONG BIO INC. Hwaseong-Si KR

Certificate No.

R1-CEP 2011-354 - Rev 00

Substance No.

1275

Issue Date

2018-07-30

End Date

2025-11-03

South Korea

Country

South Korea

Identifiers

Certificate No.: R1-CEP 2011-354 - Rev 00
Substance No.: 1275

2018
19 Jun
Chemical Valid

Product

Ursodeoxycholic acid, Process II

Substance

DAEWOONG BIO INC. Hwaseong-Si KR

Certificate No.

R1-CEP 2012-157 - Rev 00

Substance No.

1275

Issue Date

2018-06-19

End Date

-

South Korea

Country

South Korea

Identifiers

Certificate No.: R1-CEP 2012-157 - Rev 00
Substance No.: 1275

2014
20 May
Chemical Withdrawn by Holder

Product

Meropenem trihydrate

Substance

DAEWOONG BIO INC. Hwaseong-Si KR

Certificate No.

R0-CEP 2011-361 - Rev 00

Substance No.

2234

Issue Date

2014-05-20

End Date

2018-10-31

South Korea

Country

South Korea

Identifiers

Certificate No.: R0-CEP 2011-361 - Rev 00
Substance No.: 2234

2011
04 Feb
Chemical Valid

Product

Cefuroxime axetil

Substance

DAEWOONG BIO INC. Hwasung-City KR

Certificate No.

R1-CEP 2003-114 - Rev 00

Substance No.

1300

Issue Date

2011-02-04

End Date

-

South Korea

Country

South Korea

Identifiers

Certificate No.: R1-CEP 2003-114 - Rev 00
Substance No.: 1300

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    6 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
Status Breakdown
6 total
  • Valid
  • Withdrawn by holder
Official Source

All data is sourced from the official EDQM CEP database (Certification of Suitability to the European Pharmacopoeia).

Visit EDQM
Record Details Preview

Click "View Details" on any record above to expand full details inline.

Country

South Korea

Identifiers

Certificate No.: CEP 2022-479 - Rev 01
Substance No.: 1275

100% Official Data

Directly from the EDQM CEP database

Regular Updates

Data updated regularly from official sources

Trusted by Professionals

100K+ pharma professionals worldwide

Secure & Reliable

Enterprise-grade security and data protection

CEP data is obtained from the official EDQM (European Directorate for the Quality of Medicines) database.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit